Advanced stages of PD: interventional therapies and related patient-centered care
Authors:
- 3 July 2015
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 123 (1) , 31-43
Abstract
During the last decades, symptomatic treatment of motor symptoms of Parkinson’s disease (PD) improved continuously and is reflected by long-range independency of the patient during the disease course. However, advanced stages of PD still represent an important challenge to patients, caregivers and treating physicians. In patients with advanced PD, interventional therapy strategies are increasingly applied. These device-related treatment strategies using pump-based continuous dopaminergic stimulation (CDS) or deep brain stimulation (DBS) opened new treatment options especially if motor complications predominate. Well-designed clinical studies on these interventional therapeutic approaches provided class 1 evidence for the efficacy of DBS and CDS in advanced PD and opened new perspectives for their use in earlier disease stages also. Therefore, careful selection of patients amenable to the (semi)invasive therapy options becomes more and more important and requires an interdisciplinary setting that accounts for (i) optimal patient information and awareness, (ii) selection of best individual treatment modality, (iii) training of relatives and caregivers, (iv) management of complications, and (v) follow-up care. Here, we address these topics by summarizing current state-of-the-art in patient selection, providing specificities of treatment options and troubleshooting, and defining steps towards an optimized patient-centered care. Interventional therapies pioneer in the area of individualized treatment approaches for PD, and may be complemented in the future by biomarker-based improved stratification and by closed-loop systems for adaptive therapeutic strategies. In the present review, we summarize the proceedings of an Expert Workshop on Parkinson’s disease held on November 22, 2014 in Frankfurt, Germany.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (KR2119/8-1)
- Fonds National de la Recherche Luxembourg (FNR/P13/6682797)
This publication has 57 references indexed in Scilit:
- Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trialBrain, 2013
- Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based reviewJournal of Neurology, 2013
- Retrospective review of factors leading to dissatisfaction with subthalamic nucleus deep brain stimulation during long-term managementSurgical Neurology International, 2013
- The Benefit of Subthalamic Deep Brain Stimulation for Pain in Parkinson DiseaseNeurosurgery, 2012
- Rotigotine transdermal patch in combination therapy for Parkinson’s disease – observations in routine clinical practiceCurrent Medical Research and Opinion, 2011
- What is the best treatment for fluctuating Parkinson’s disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?Journal of Neural Transmission, 2010
- Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's diseaseMovement Disorders, 2009
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled TrialJAMA, 2009
- Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutationsMovement Disorders, 2007
- Deep brain stimulationCell and tissue research, 2004